Replies to post #243323 on Biotech Values

[DewDiligence]

Doesn't seem like a [Mavyret] post-covid pop is in the works.

Mavyret sales were +5% QoQ (#msg-169533885), so there was no “pop” but there was some recovery. HCV patients who don’t die off are still going to need treatment eventually.